Skip to main content
. Author manuscript; available in PMC: 2022 Jul 19.
Published in final edited form as: Pharm Res. 2022 Mar 3;39(7):1587–1598. doi: 10.1007/s11095-022-03218-w

Fig. 3. Permeability coefficient of Nln activators in MDR1-MDCA P-gp overexpressed cell monolayer.

Fig. 3

(A) Permeability of Nln activators in the presence and absence of P-gp inhibitor (CsA) (n = 4). (B) Permeability of Nln activators in apical to basolateral (A > B) and basolateral to apical (B > A) direction (n = 3).